As the burden of diabetes continues to rise in India, diabetic retinopathy has emerged as one of its most debilitating complications—often leading to irreversible vision loss if left undiagnosed.

Diabetic neuropathy is the most common neuropathy in industrialized countries, and it is associated with a wide range of clinical manifestations. The vast majority of patients with clinical ...

Unmanaged diabetes can lead to amputations, usually of the toes, feet, or legs. Causes include reduced blood flow or peripheral neuropathy. Managing your blood sugar may help prevent it.

Type 2 diabetes also puts you at risk for certain health conditions that can reduce life expectancy. Type 2 diabetes typically shows up later in life, although the incidence in younger people is ...

Recent research indicates that semaglutide, a medication often prescribed for diabetes management, may be associated with an elevated risk of developing nonarteritic anterior ischemic optic neuropathy ...

Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...

Diabetes test results show whether your blood sugar levels are normal, in the prediabetes range, or high enough to indicate diabetes. A fasting blood sugar test under 99 mg/dL is normal, between 100 ...

WASHINGTON: A new American study has shown that diabetes during pregnancy is associated with an increased risk of brain and nervous system problems in children, particularly autism. The study, ...

Diabetes is known to cause many medical issues, from heart disease to vision problems — and now a new study suggests it could also impact memory and other cognitive functions. After observing ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date ...

More information: Alan Y. Hsu et al, Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.0349 ...